Estudio de utilización y descripción de costes de eritropoyetina en pacientes hematológicos.

Autores de IIS La Fe

• Ana Pelufo Pellicer

  Autor

• Emilio Monte Boquet

  Autor

• José Luis Poveda Andrés

  Autor

• María Jesús Cuellar Monreal

  Autor

Abstract

To assess the effectiveness of erythropoietin use in hematologic patients; to analyze the extent to which recommendations are applied as provided by Spanish prescribing information, American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) guidelines, as well as specific recommendations for myelodysplastic syndromes (MDSs), and to perform a descriptive analysis of costs.